Azerbaijan vs Other small states: Access to anti-retroviral drugs, female
Azerbaijan
98.0%
in 2024
Other small states
94.0%
in 2022
Azerbaijan rank
1st
Other small states rank
1st
Access to anti-retroviral drugs, female over time
- Azerbaijan
- Other small states
How they compare
Azerbaijan currently reports 98.0% against 94.0% in Other small states, a difference of 4.0%.
Across all 19 years both countries report, Other small states has been ahead every year.
Azerbaijan ranks 1st and Other small states ranks 1st of 141 countries.
Other small states has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.2% | 7.5% | 6.4% | Other small states |
| 2010s | 32.0% | 62.1% | 30.1% | Other small states |
| 2020s | 77.0% | 93.8% | 16.8% | Other small states |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Azerbaijan or Other small states?
- Azerbaijan, at 98.0% against 94.0% in Other small states as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Azerbaijan and Other small states?
- 4.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Other small states?
- 19 years are reported by both, from 2000 to 2022.
- How do Azerbaijan and Other small states rank globally for access to anti-retroviral drugs, female?
- Azerbaijan ranks 1st and Other small states ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.